These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7130827)

  • 1. Megakaryocytopoiesis and granulopoiesis following cyclophosphamide.
    Petursson SR; Chervenick PA
    J Lab Clin Med; 1982 Nov; 100(5):682-94. PubMed ID: 7130827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compensatory mechanisms in platelet production: lack of a paracrine response in W/Wv mice treated with 5-fluorouracil.
    Arnold JT; Radley JM; Williams NT
    Exp Hematol; 1993 Mar; 21(3):414-9. PubMed ID: 8440339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion of interleukin-6 in sublethally irradiated mice accelerates platelet reconstitution and the recovery of myeloid but not of megakaryocytic progenitor cells in bone marrow.
    Laterveer L; van Damme J; Willemze R; Fibbe WE
    Exp Hematol; 1993 Dec; 21(13):1621-7. PubMed ID: 8243564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined interleukin-1 beta/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression.
    Tritarelli E; Greco G; Testa U; Belardelli F; Peschle C; Proietti E
    Cancer Res; 1994 Dec; 54(24):6469-76. PubMed ID: 7987845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Megakaryocytopoiesis and granulopoiesis after murine cytomegalovirus infection.
    Petursson SR; Chervenick PA; Wu B
    J Lab Clin Med; 1984 Sep; 104(3):381-90. PubMed ID: 6088656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of rhG-CSF scheduling on megakaryocytopoietic recovery following 5-fluorouracil-induced hematotoxicity in splenectomized B6D2F1 mice.
    Scheding S; Media JE; Nakeff A
    Stem Cells; 1998; 16(2):144-51. PubMed ID: 9554039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cyclophosphamide on murine bone marrow and splenic megakaryocyte-CFC, granulocyte-macrophage-CFC, and peripheral blood cell levels.
    Yeager AM; Levin FC; Levin J
    J Cell Physiol; 1982 Aug; 112(2):222-8. PubMed ID: 7119022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Megakaryocytopoiesis in the rat: response to thrombocytopenia induced by exchange transfusion.
    Kimura H; Segal GM; Lee MY; Adamson JW
    Exp Hematol; 1985 Nov; 13(10):1048-54. PubMed ID: 4054245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constant subcutaneous infusion of rhIL-11 in mice: efficient delivery enhances biological activity.
    Leonard JP; Neben TY; Kozitza MK; Quinto CM; Goldman SJ
    Exp Hematol; 1996 Feb; 24(2):270-6. PubMed ID: 8641352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenic granulopoiesis in mice following administration of cyclophosphamide.
    Joyce RA; Hartmann O; Chervenick PA
    Cancer Res; 1979 Jan; 39(1):215-8. PubMed ID: 761191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
    Gallicchio VS; Hughes NK; Tse KF
    Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis.
    Nagata Y; Shozaki Y; Nagahisa H; Nagasawa T; Abe T; Todokoro K
    Thromb Haemost; 1997 May; 77(5):808-14. PubMed ID: 9184382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of in vivo administration of stem cell factor on thrombopoiesis in normal and immunodeficient mice.
    Chow FP; Zsebo K; Hamburger AW
    Exp Hematol; 1993 Aug; 21(9):1255-62. PubMed ID: 7687220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of spleen cell conditioned medium on megakaryocytopoiesis in a short-term bone marrow culture system.
    Petursson SR; Chervenick PA
    J Lab Clin Med; 1988 Jan; 111(1):110-7. PubMed ID: 3335820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential differentiation of murine CFU-S toward granulopoiesis and megakaryocytopoiesis after in vitro incubation of bone marrow with ASTA-Z 7557.
    Sainteny F; Lopez M; Mary JY; Frindel E
    Exp Hematol; 1987 Jul; 15(6):631-5. PubMed ID: 3297759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacillus Calmette-Guérin enhancement of colony-stimulating activity and myeloid colony formation following administration of cyclophosphamide.
    Ladisch S; Reaman GH; Poplack DG
    Cancer Res; 1979 Jul; 39(7 Pt 1):2544-6. PubMed ID: 445455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified thrombopoietic response to 5-FU in mice following transplantation of Lin-Sca-1+ bone marrow cells.
    Arnold JT; Barber L; Bertoncello I; Williams NT
    Exp Hematol; 1995 Feb; 23(2):161-7. PubMed ID: 7828673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo effects of KT6352, a derivative of indolocarbazole compounds, on murine megakaryocytopoiesis.
    Shiotsu Y; Akinaga S; Yamashita K; Murakata C; Tamaoki T; Ishida Y; Kuriya S; Teramura M; Mizoguchi H
    Exp Hematol; 1998 Dec; 26(13):1195-201. PubMed ID: 9845374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of rhIL-11 on normal dogs and after sublethal radiation.
    Nash RA; Seidel K; Storb R; Slichter S; Schuening FG; Appelbaum FR; Becker AB; Bolles L; Deeg HJ; Graham T
    Exp Hematol; 1995 May; 23(5):389-96. PubMed ID: 7720811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.